Related Experiment Video
Updated: May 17, 2026

Platelet-Derived Extracellular Vesicle Functionalization of Ti Implants
Published on: August 5, 2021
Drug delivery from hydroxyapatite-coated titanium surfaces using biodegradable particle carriers
Jun Sik Son1, Young-Ae Choi, Eui-Kyun Park
1Institute for Biomaterials Research & Development, Kyungpook National University, Daegu, Republic of Korea.
This study developed a functional titanium implant using drug-loaded biodegradable particles to enhance bone regeneration. The novel implant effectively promoted stem cell differentiation for dental applications.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Dental Implantology
Background:
- Developing functional titanium implants is crucial for dental applications.
- Biodegradable polymeric particles offer potential as drug delivery carriers for bioactive molecules.
- Enhancing osseointegration and bone regeneration around implants remains a key challenge.
Purpose of the Study:
- To create a functional titanium implant loaded with bioactive molecules using biodegradable polymeric particles.
- To investigate the immobilization and release of dexamethasone (DEX)-loaded poly(lactic-co-glycolic acid) (PLGA) particles on hydroxyapatite (HA)-coated titanium (Ti) surfaces.
- To evaluate the in vitro efficacy of the developed implant in promoting bone marrow-derived mesenchymal stem cell (BMSC) differentiation.
Main Methods:
- Fabrication of titanium discs: RBM Ti (S1), HA-Ti (S2), and HA-Ti with DEX-loaded PLGA particles (S3).
- Electrostatic immobilization of polyethyleneimine (PEI)-coated PLGA particles onto HA-Ti surfaces using a low temperature high speed collision (LTHSC) method.
- In vitro release studies of DEX and BMSC culture experiments to assess cell differentiation.
Main Results:
- DEX-loaded PLGA particles were successfully immobilized onto HA-Ti surfaces (S3).
- A 4-week immersion study showed an initial burst release followed by sustained DEX release from S3 discs.
- S3 discs significantly enhanced BMSC differentiation compared to S1 and S2 discs in vitro.
Conclusions:
- The developed functional titanium implant effectively delivers bioactive molecules, promoting BMSC differentiation.
- This innovative drug delivery platform shows promise for stem cell therapy and enhancing in vivo osteogenesis.
- Biodegradable polymeric particles are efficient for incorporating various bone regeneration-promoting molecules onto HA-Ti surfaces.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted
Oral Drug Delivery Systems: Delayed-Release Systems
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Rate-Programmed I

